Response to Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines"
- PMID: 35418502
- PMCID: PMC11076016
- DOI: 10.4049/jimmunol.2101067
Response to Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines"
Comment on
-
Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines.J Immunol. 2021 Nov 15;207(10):2405-2410. doi: 10.4049/jimmunol.2100637. Epub 2021 Oct 15. J Immunol. 2021. PMID: 34654691 Free PMC article.
-
Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines".J Immunol. 2022 Apr 15;208(8):1833. doi: 10.4049/jimmunol.2101082. J Immunol. 2022. PMID: 35418503 No abstract available.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources